Growth Metrics

Axogen (AXGN) Shareholder's Equity Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Axogen 2.00 Bn 1.90 Bn 46.19 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 132.34%
Dec 31, 2025 24.00%
Sep 30, 2025 21.53%
Jun 30, 2025 17.34%
Mar 31, 2025 13.11%
Dec 31, 2024 8.62%
Sep 30, 2024 1.63%
Jun 30, 2024 -1.51%
Mar 31, 2024 -4.47%
Dec 31, 2023 -5.28%
Sep 30, 2023 -3.58%
Jun 30, 2023 -4.46%
Mar 31, 2023 -6.10%
Dec 31, 2022 -10.26%
Sep 30, 2022 -12.00%
Jun 30, 2022 -14.33%
Mar 31, 2022 -13.24%
Dec 31, 2021 -8.61%
Sep 30, 2021 -5.28%
Jun 30, 2021 -0.88%
Mar 31, 2021 -3.62%
Dec 31, 2020 -6.81%
Sep 30, 2020 -10.12%
Jun 30, 2020 -13.19%
Mar 31, 2020 -11.76%
Dec 31, 2019 -10.09%
Sep 30, 2019 -9.41%
Jun 30, 2019 -8.33%
Mar 31, 2019 548.82%
Dec 31, 2018 483.68%
Sep 30, 2018 1,316.58%
Jun 30, 2018 1,230.85%
Mar 31, 2018 78.91%
Dec 31, 2017 68.77%
Sep 30, 2017 856.10%
Jun 30, 2017 304.88%
Mar 31, 2017 150.55%
Dec 31, 2016 82.05%
Sep 30, 2016 -90.12%
Jun 30, 2016 179.12%
Mar 31, 2016 811.12%
Dec 31, 2015 172.88%
Sep 30, 2015 209.72%
Jun 30, 2015 50.80%
Mar 31, 2015 81.57%
Dec 31, 2014 -8,330.57%
Sep 30, 2014 -347.57%
Jun 30, 2014 22.83%
Mar 31, 2014 38.51%
Dec 31, 2013 104.83%
Sep 30, 2013 241.44%
Jun 30, 2013 -384.31%
Mar 31, 2013 -245.76%
Dec 31, 2012 -146.60%
Sep 30, 2012 -84.86%
Jun 30, 2012 -71.68%
Dec 31, 2011 122.39%